In addition, normalization of hyperglycemia by treatment with a SGLT-2 inhibitor for 7 days before the clamp study normalized the increase in GC in response to hyperglycemia but did not alter the elevated basal GC (28, 35). Here, SLC5A2 is linked to Hyperglycemia.